Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Strategy Briefing

Global Developments in Respiratory Remedies

Oct 2016

US$1,325

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

About This Report

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

While growing interest in immune system fortification and good health practices reduce the overall prevalence of illness, climate change and pollution endanger respiratory health. These natural and man-made forces foment unpredictability in the respiratory remedies market, yet it continues to experience dynamic growth and innovation around the world.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Moderate forecast growth translates to major absolute growth in respiratory remedies

The US$33.5 billion cough, cold and allergy remedies industry is expected to grow at 2% annually through 2021, generating an additional US$3.4 billion in retail value by that year. North America and Asia Pacific are key regions, as they will account for over half of that increase. The larger markets of the US, China and Brazil are critical contributors, while Pakistan and South Africa will be countries to watch for high percentage growth.

Acquisitions and joint ventures reshape the competitive space

Major corporate activity, including Bayer’s 2014 acquisition of Merck & Co’s consumer care division and GlaxoSmithKline and Novartis’s 2015 consumer health joint venture, are redefining what it means to be a global leader in respiratory remedies. Sanofi’s anticipated acquisition of Boehringer Ingelheim’s consumer health segment (excluding China) will continue to consolidate the competitive landscape.

Global air quality and weather patterns exert strong and growing effects on respiratory health

Air pollution in urban areas and global climate change resulting in prolonged pollen seasons are exacerbating respiratory illness. The former factor in particular is highly correlated with retail value growth in cough, cold and allergy remedies, and is only expected to deteriorate further. Children growing up in this atmosphere are more prone to developing allergies and constitute a broadening consumer base for the allergy care category.

New products, improved access and innovation in advertising critical for maintaining momentum

Product development, particularly as a result of Rx-to-OTC switches, expanded access to standard formulations in developing countries, as well as creative advertising in the digital age are increasingly impactful and predicted to be primary growth drivers over the forecast period.

Want to find out more about this report?

Request more information

Introduction

Scope

Global cough, cold and allergy (hay fever) remedies retail sales in 2016

Key findings

Global Overview of Cough, Cold and Allergy Remedies

Cough, cold and allergy remedies dominates the OTC landscape

Cough, cold and allergy remedies retail sales in the world in 2016

Asia Pacific and North America lead in retail sales value

Cough, cold and allergy remedies by type

Vitamins and dietary supplements that fend off coughs and colds

OTC allergy remedies outside of the respiratory space

Mergers and acquisitions activity reshapes competitive landscape

Performance review of top brands

Major Trends in Respiratory Health

Pollen and pollution contribute to greater incidence of respiratory illness

Regulatory changes both encourage growth and impose limitations

Drugstores and pharmacies still top distribution channel

The US is ahead in innovation: Three 2016 launches

Herbal/traditional remedies also in the spotlight

A dvertising gets creative with digital and experiential formats

Developed markets still carrying global sales

Regional Analysis

Asia Pacific maintains strong growth

Combination remedies leads category in Asia Pacific

Country spotlight: China

North American market increasingly consolidated

North American markets heavily impacted by regulation

Country spotlight: US

Western Europe experiences rocky growth

Allergy categories attain robust growth in Western Europe

Country spotlight: Germany

Latin America’s rapid growth expected to plateau

Combination products gaining traction in Latin America

Country spotlight: Mexico

Eastern Europe’s mid-size markets lead growth

Eastern Europe sees strong performance from paediatric CCA

Country spotlight: Russia

Fast-growing MEA market depends heavily on international brands

MEA led by combination products, sees fast growth in nasal sprays

Country spotlight: South Africa

Australasia lags in sales growth, faces regulatory burdens

Australasia’s CCA market led by combination products and antihistamines

Country spotlight: New Zealand

Looking Ahead

Forecast compound annual growth rates by region and category

Respiratory remedy forecast growth largely supported by few markets

Developing nations predicted to extend lead in absolute retail value growth

Largest categories predicted to drive global growth

Appendix

Data parameters and report definitions

Product definitions (1)

Product definitions (2)

Product definitions (3)

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Strategy Briefing

Global Developments in Respiratory Remedies

New Report Guarantee

About This Report

New Report Guarantee

Overview

Why buy this report?

Moderate forecast growth translates to major absolute growth in respiratory remedies

Acquisitions and joint ventures reshape the competitive space

Global air quality and weather patterns exert strong and growing effects on respiratory health

New products, improved access and innovation in advertising critical for maintaining momentum

Want to find out more about this report?

Table of Contents

Introduction

Scope

Global cough, cold and allergy (hay fever) remedies retail sales in 2016

Key findings

Global Overview of Cough, Cold and Allergy Remedies

Cough, cold and allergy remedies dominates the OTC landscape

Cough, cold and allergy remedies retail sales in the world in 2016

Asia Pacific and North America lead in retail sales value

Cough, cold and allergy remedies by type

Vitamins and dietary supplements that fend off coughs and colds

OTC allergy remedies outside of the respiratory space

Mergers and acquisitions activity reshapes competitive landscape

Performance review of top brands

Major Trends in Respiratory Health

Pollen and pollution contribute to greater incidence of respiratory illness

Regulatory changes both encourage growth and impose limitations

Drugstores and pharmacies still top distribution channel

The US is ahead in innovation: Three 2016 launches

Herbal/traditional remedies also in the spotlight

A dvertising gets creative with digital and experiential formats

Developed markets still carrying global sales

Regional Analysis

Asia Pacific maintains strong growth

Combination remedies leads category in Asia Pacific

Country spotlight: China

North American market increasingly consolidated

North American markets heavily impacted by regulation

Country spotlight: US

Western Europe experiences rocky growth

Allergy categories attain robust growth in Western Europe

Country spotlight: Germany

Latin America’s rapid growth expected to plateau

Combination products gaining traction in Latin America

Country spotlight: Mexico

Eastern Europe’s mid-size markets lead growth

Eastern Europe sees strong performance from paediatric CCA

Country spotlight: Russia

Fast-growing MEA market depends heavily on international brands

MEA led by combination products, sees fast growth in nasal sprays

Country spotlight: South Africa

Australasia lags in sales growth, faces regulatory burdens

Australasia’s CCA market led by combination products and antihistamines

Country spotlight: New Zealand

Looking Ahead

Forecast compound annual growth rates by region and category

Respiratory remedy forecast growth largely supported by few markets

Developing nations predicted to extend lead in absolute retail value growth

Largest categories predicted to drive global growth

Appendix

Data parameters and report definitions

Product definitions (1)

Product definitions (2)

Product definitions (3)

Related content available in Passport

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Strategy Reports

Country Reports

Recently Viewed

Complete Catalogue

Strategy Reports

Country Reports